Home > Share Market > Stocks > Glaxosmithkline pharmaceuticals > Financial Statements> GLAXO Profit & Loss

Glaxosmithkline Pharmaceuticals Ltd Financial Statements

Profit & Loss Statement of Glaxosmithkline Pharmaceuticals Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2017 Mar-2016
Revenue 3,199 3,224 2,908 2,838
yoy growth (%) (0.80) 10.90 2.49 (14)
Raw materials (1,313) (1,308) (1,398) (1,233)
As % of sales 41 40.60 48.10 43.50
Employee costs (615) (629) (483) (443)
As % of sales 19.20 19.50 16.60 15.60
Other costs (576) (631) (609) (683)
As % of sales 18 19.60 20.90 24.10
Operating profit 695 657 419 478
OPM 21.70 20.40 14.40 16.90
Depreciation (79) (83) (26) (25)
Interest expense (3.50) (6.30) (0.30) (0.20)
Other income 111 79 73.10 123
Profit before tax 723 647 465 576
Taxes (192) (213) (174) (202)
Tax rate (27) (33) (37) (35)
Minorities and other -- -- -- --
Adj. profit 531 435 291 374
Exceptional items (173) (341) 45.70 2.31
Net profit 358 93.20 337 376
yoy growth (%) 284 (72) (10) (21)
NPM 11.20 2.89 11.60 13.30

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000